Chair: L7 followed by L11 – L9, L4, L10, L6. Can we be conscious of the clock please and maintain spirit of flexibility. Norway: A brief presentation of this resolution. Without any intervention a large number of pregnant women will transfer the virus to their babies. Providing antiviral drugs has a dramatic reduction in transmission …
New Zealand
Plenary: Item 3 General Debate (Tuesday 13th – Afternoon Session)
Malaysia: The number of drug users continues to rise and uses measures to protect its people. Malaysia stands firm against the legalisation of drugs. Our policy policy both incorporates demand and supply reduction. We are taking the necessary steps to reduce drug addiction as well as prevention and treatment. We take measures against all trafficking …
Side event: Health responses to New Psychoactive Substances
Organised by the Governments of the United Kingdom and New Zealand, and the UNODC Laboratory and Scientific Section. Opening Remarks from HE Leigh Turner – UK Permanent Representative to the UN Vienna Thank you and welcome. There is growing evidence of the impact of these substances. The UK has been working with its partners to …
CND Plenary – Opening of the Sixtieth Session of the Commission on Narcotic Drugs (Monday, March 13, 2017 – Morning)
Item 2. Adoption of the agenda and other organisational matters Chair: I hereby declare the 60th Session of the CND open. Agenda item 8 will start with subitem B on Thursday morning. Propose that the CND adopt the agenda as it is written. I see no objections. It is so decided. Youth Initiative: Thank you …
Thirtieth special session of the General Assembly on the world drug problem (2nd plenary meeting)
The full statements delivered by member states during the UNGASS general debate are available here. Chair: We will resume the agenda. India: This is an Historic special session. We are meeting after 2009 political declaration, just months after we adopted SDPs. The Drug problem impacts our ability to achieve this agenda. The three conventions have …
UNGASS Roundtable 1: Demand reduction and related measures
Demand reduction and related measures, including prevention and treatment, as well as health-related issues; an ensuring the availability of controlled substances for medical and scientific purposes, while preventing their diversion. (‘Drugs and health’) Chair: in order to encourage an interactive discussion, this will be conducted without a list of speakers. All participants at round tables …